The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)
Open accessAbstract
AIMS: Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death (SCD) in young adults. Current risk algorithms provide only a crude estimate of risk and fail to account for the different effect size of individual risk factors. The aim of this study was to develop and validate a new SCD risk prediction model that provides individualized risk estimates. METHODS AND RESULTS: The prognostic model was derived from a retrospective, multi-centre longitudinal cohort study. The model was developed from the entire data set using the Cox proportional hazards model and internally validated using bootstrapping. The cohort consisted of 3675 consecutive patients from six centres. During a follow-up period of 24 313 patient-years (median 5.7 years), 198 patients (5%) died suddenly or had an appropriate implantable cardioverter defibrillator (ICD) shock. Of eight pre-specified predictors, age, maximal left ventricular wall thickness, left atrial diameter, left ventricular outflow tract gradient, family history of SCD, non-sustained ventricular tachycardia, and unexplained syncope were associated with SCD/appropriate ICD shock at the 15% significance level. These predictors were included in the final model to estimate individual probabilities of SCD at 5 years. The calibration slope was 0.91 (95% CI: 0.74, 1.08), C-index was 0.70 (95% CI: 0.68, 0.72), and D-statistic was 1.07 (95% CI: 0.81, 1.32). For every 16 ICDs implanted in patients with ≥4% 5-year SCD risk, potentially 1 patient will be saved from SCD at 5 years. A second model with the data set split into independent development and validation cohorts had very similar estimates of coefficients and performance when externally validated. CONCLUSION: This is the first validated SCD risk prediction model for patients with HCM and provides accurate individualized estimates for the probability of SCD using readily collected clinical parameters.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In general, a history of syncope in patients with structural heart disease or inheritable arrhythmia syndromes is associated with a two- to four-fold increased risk of death, 348,350-353 but varies between specific conditions. 354-356”
From 2018 ESC Guidelines for the diagnosis and management of syncope (2018) · cites this paper as [350]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the largest multicentre study to date (>3600 patients with HCM), syncope was an independent predictor of the composite of SCD and ICD discharge (hazard ratio 2.05, 95% CI 1.48-2.82). 350”
From 2018 ESC Guidelines for the diagnosis and management of syncope (2018) · cites this paper as [350]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“LVOT obstruction has been identified as a predictor of sudden death in some but not all studies”
From Current management of hypertrophic cardiomyopathy (2025) · cites this paper as [98]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“initially validated in 2013.”
From Current management of hypertrophic cardiomyopathy (2025) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Multiple imputation using chained equations: Issues and guidance for practice
White, I. R., Royston, P., & Wood, A. M. (2011) · Statistics in Medicine · doi:10.1002/sim.4067 · Cited by 9,792
Regression Modeling Strategies
Harrell, F. E. (2001) · Springer series in statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,270
Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating
Steyerberg, E. W. (2019) · Statistics for Biology and Health · doi:10.1007/978-3-030-16399-0 · Cited by 3,281
Partial residuals for the proportional hazards regression model
SCHOENFELD, D. (1982) · Biometrika · doi:10.1093/biomet/69.1.239 · Cited by 3,111
Elliot, P. M., Andersson, B., Arbustini, E., Bilińska, Z. T., Cecchi, F., Charron, P., Dubourg, O., Kühl, U., Maisch, B., McKenna, W. J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm342 · Cited by 2,995
Self-citationPeduzzi, P., Concato, J., Feinstein, A. R., & Holford, T. R. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00048-8 · Cited by 2,154
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,116
Prognosis and prognostic research: what, why, and how?
Moons, K. G. M., Royston, P., Vergouwe, Y., Grobbee, D. E., & Altman, D. G. (2009) · BMJ · doi:10.1136/bmj.b375 · Cited by 1,337
Maron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,259
Research works printed but not linked: 1
- 2012, Circulation: Arrhythmia and Electrophysiology, 6, 443
Cited by
Sorted by citations
Items 301–400 of 999
Dong, Y., Yang, W. J., Chen, C., Ji, J., Zheng, W., Zhang, F., Yang, B., Li, X., & Zhou, X. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.691653 · Cited by 24
Rowin, E. J., Maron, M. S., Adler, A., Albano, A. J., Varnava, A. M., SPEARS, D. A., Marsy, D., Heitner, S. B., Cohen, E., Leong, K. M. W., et al. (2021) · Heart Rhythm · doi:10.1016/j.hrthm.2021.12.017 · Cited by 24
Disease Progression of Hypertrophic Cardiomyopathy: Modeling Using Machine Learning
Pičulin, M., Smole, T., Žunkovič, B., Kokalj, E., Robnik‐Šikonja, M., Kukar, M., Fotiadis, D. I., Pezoulas, V. C., Tachos, N. S., Barlocco, F., et al. (2022) · JMIR Medical Informatics · doi:10.2196/30483 · Cited by 26
Norrish, G., Ding, T., Field, E., Cervi, E., Ziółkowska, L., Olivotto, I., Khraiche, D., Limongelli, G., Anastasakis, A., Weintraub, R. G., et al. (2022) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.121.010075 · Cited by 24
Self-citationGragnano, F., Pelliccia, F., Guarnaccia, N., Niccoli, G., Rosa, S. D., Piccolo, R., Moscarella, E., Fabris, E., Montone, R. A., Cesaro, A., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12082810 · Cited by 24
Heterogeneity in a large pedigree with Danon disease: Implications for pathogenesis and management
Roos, J. C. P., Daniels, M. J., Morris, E., Hyry, H. I., & Cox, T. M. (2017) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2017.06.008 · Cited by 24
Shimada, Y. J., Hoeger, C. W., Latif, F., Takayama, H., Ginns, J. N., & Maurer, M. S. (2019) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2019.03.016 · Cited by 24
Schick, A. R., Hayes, G. M., Singh, A., Mathews, K. G., Higginbotham, M. L., & Sherwood, J. M. (2019) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/vec.12838 · Cited by 24
Hwang, I., Cho, G., Choi, H., Yoon, Y. E., Park, J. J., Park, J., Park, J., Lee, S., Kim, H., Kim, Y.-J., et al. (2019) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jez300 · Cited by 24
Magrì, D., Mastromarino, V., Gallo, G., Zachara, E., Re, F., Agostoni, P., Giordano, D., Rubattu, S. D., Forte, M., Cotugno, M., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061636 · Cited by 24
Sugrue, A. M., Killu, A. M., DeSimone, C. V., Chahal, C. A. A., Vogt, J. C., Křemen, V., Hai, J. J., Hodge, D. O., Acker, N. G., Geske, J. B., et al. (2017) · Open Heart · doi:10.1136/openhrt-2016-000561 · Cited by 26
Kim, H. Y., Park, J. E., Lee, S., Jeon, E., On, Y. K., Kim, S. M., Choe, Y. H., Ki, C., Kim, J., & Kim, K. H. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061671 · Cited by 23
Wolf, C. M., Zenker, M., Burkitt‐Wright, E., Édouard, T., García‐Miñáur, S., Lebl, J., Shaikh, M. G., Tartaglia, M., Verloès, A., & Östman‐Smith, I. (2021) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2021.104372 · Cited by 23
Aung, N., Lopes, L. R., van Duijvenboden, S., Harper, A. R., Goel, A., Grace, C., Ho, C. Y., Weintraub, W. S., Kramer, C. M., Neubauer, S., et al. (2023) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.122.003716 · Cited by 23
Hasler, S., Manka, R., Greutmann, M., Gämperli, O., Schmied, C. M., Tanner, F., Biaggi, P., Lüscher, T. F., Keller, D. I., & Gruner, C. (2016) · Swiss Medical Weekly · doi:10.4414/smw.2016.14285 · Cited by 23
Cardiac Screening of Young Athletes: a Practical Approach to Sudden Cardiac Death Prevention
Dhutia, H., & MacLachlan, H. (2018) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-018-0681-4 · Cited by 23
Hypertrophic cardiomyopathy: Sudden cardiac death risk stratification in adults
Jordà, P., & García‐Álvarez, A. (2018) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2018.25 · Cited by 22
Advanced imaging for risk stratification of sudden death in hypertrophic cardiomyopathy
Ramchand, J., Fava, A. M., Chetrit, M., & Desai, M. Y. (2020) · Heart · doi:10.1136/heartjnl-2019-315176 · Cited by 23
Liu, J., Wu, G., Zhang, C., Ruan, J., Wang, D., Zhang, M., Wang, L., Yang, Y., Li, X., Wang, Y., et al. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.04.017 · Cited by 23
Miles, C. J., Fanton, Z., Tome, M., & Behr, E. R. (2019) · BMJ · doi:10.1136/bmj.l1570 · Cited by 23
McKenna, W. J., Asaad, N., & Jacoby, D. L. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz195 · Cited by 22
Self-citationImpact of exercise-induced mitral regurgitation on hypertrophic cardiomyopathy outcomes
Fénéon, D., Schnell, F., Galli, E., Bernard, A. B., Mabo, P., Daubert, J., Leclercq, C., Carré, F., & Donal, E. (2015) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jev242 · Cited by 23
Empowerment of athletes with cardiac disorders: a new paradigm
Providencia, R. A., Teixeira, C., Segal, O. R., Ullstein, A., Mueser, K. T., & Lambiase, P. D. (2017) · EP Europace · doi:10.1093/europace/eux268 · Cited by 22
Orgeron, G. M., Riele, A. S. J. M. T., Tichnell, C., Wang, W., Murray, B. A., Bhonsale, A., Judge, D. P., Kamel, I. R., Zimmerman, S. L., Tandri, H. S., et al. (2018) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.117.005593 · Cited by 22
Epilepsy Risk Prediction Model for Patients With Tuberous Sclerosis Complex
Farach, L. S., Richard, M. A., Lupo, P. J., Şahin, M., Krueger, D. A., Wu, J. Y., Bebin, E. M., Au, K. S., Northrup, H., Şahin, M., et al. (2020) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2020.07.015 · Cited by 22
Childhood Hypertrophic Cardiomyopathy: A Disease of the Cardiac Sarcomere
Norrish, G., Field, E., & Kaski, J. P. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.708679 · Cited by 23
Applications of artificial intelligence in urological setting: a hopeful path to improved care
Eun, S.-J., Kim, J., & Kim, K. H. (2021) · Journal of Exercise Rehabilitation · doi:10.12965/jer.2142596.298 · Cited by 22
Mathai, S., & Williams, L. K. (2022) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223221136074 · Cited by 22
Fumagalli, C., Bonanni, F., Beltrami, M., Ruggieri, R., Zocchi, C., Tassetti, L., Maurizi, N., Berteotti, M., Zampieri, M., Argirò, A., et al. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.04.008 · Cited by 22
Nakagawa, S., Okada, A., Nishimura, K., Hamatani, Y., Amano, M., Takahama, H., Amaki, M., Hasegawa, T., Kanzaki, H., Kusano, K., et al. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.08.042 · Cited by 22
Rowin, E. J., Maron, B. J., Romashko, M. D., Wang, W., Rastegar, H., Link, M. S., & Maron, M. S. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.04.002 · Cited by 22
Manual zur Diagnostik und Therapie von Synkopen
von Scheidt, W., Bosch, R., Klingenheben, T., Schuchert, A., Stellbrink, C., & Stockburger, M. (2019) · Der Kardiologe · doi:10.1007/s12181-019-0319-0 · Cited by 21
Wang, J., Zhang, J., Liu, W., Pu, L., Qi, W., Xu, Y., Wan, K., Gkoutos, G. V., Han, Y., & Chen, Y. (2025) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.124.017174 · Cited by 25
Multimodality Cardiac Imaging in Cardiomyopathies: From Diagnosis to Prognosis
Casas, G., & Rodríguez-Palomares, J. F. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030578 · Cited by 21
Schoonvelde, S. A. C., Wiethoff, I., Zwetsloot, P.-P. M., Hirsch, A., Knackstedt, C., Germans, T., Sikking, M. A., Schinkel, A. F. L., van Slegtenhorst, M. A., Verhagen, J. M. A., et al. (2024) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcae092 · Cited by 21
Zhang, C., Liu, R., Yuan, J., Cui, J., Hu, F., Yang, W., Zhang, Y., Yang, C., & Qiao, S. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.09.006 · Cited by 21
J Waves for Predicting Cardiac Events in Hypertrophic Cardiomyopathy
Tsuda, T., Hayashi, K., Konno, T., Sakata, K., Fujita, T., Hodatsu, A., Nagata, Y., Teramoto, R., Nomura, A., Tanaka, Y., et al. (2017) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2017.03.010 · Cited by 21
Development of and Progression of Overt Heart Failure in Nonobstructive Hypertrophic Cardiomyopathy
Hiemstra, Y. L., Debonnaire, P., van Zwet, E. W., Bootsma, M., Schalij, M. J., Bax, J. J., Delgado, V., & Marsan, N. A. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.04.038 · Cited by 21
Evaluation of Hypertrophic Cardiomyopathy: Newer Echo and MRI Approaches
Habib, M., Hoss, S., & Rakowski, H. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1173-1 · Cited by 21
Machine Learning for Predicting Heart Failure Progression in Hypertrophic Cardiomyopathy
Fahmy, A. S., Rowin, E. J., Manning, W. J., Maron, M. S., & Nezafat, R. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.647857 · Cited by 19
Yang, Y., Ji, Z., Zhou, W., Pu, C., Li, Y., Zhou, C., Hu, X., Chen, C., Sun, Y., Huang, Q., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.758635 · Cited by 20
The Risk of Sudden Death in Children with Hypertrophic Cardiomyopathy
Norrish, G., & Kaski, J. P. (2021) · Heart Failure Clinics · doi:10.1016/j.hfc.2021.07.012 · Cited by 20
Artificial Intelligence in Ventricular Arrhythmias and Sudden Death
Holmström, L. T. A., Zhang, Z., Ouyang, D., Dey, D., Slomka, P. J., & Chugh, S. S. (2023) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2022.42 · Cited by 21
Henein, M. Y., Arvidsson, S., Pilebro, B., Backman, C., Mörner, S., & Lindqvist, P. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.03.041 · Cited by 20
Risk Stratification in Hypertrophic Cardiomyopathy
Steriotis, A. K., & Sharma, S. (2015) · European Cardiology Review · doi:10.15420/ecr.2015.10.01.31 · Cited by 20
QT spatial dispersion and sudden cardiac death in hypertrophic cardiomyopathy: Time for reappraisal
Magrì, D., Santolamazza, C., Limite, L. R., Mastromarino, V., Casenghi, M., Orlando, P., Pagannone, E., Musumeci, B., Maruotti, A., Ricotta, A., et al. (2017) · Journal of Cardiology · doi:10.1016/j.jjcc.2017.01.006 · Cited by 20
Implantable cardioverter–defibrillator therapy in hypertrophic cardiomyopathy: A SIMPLE substudy
Vámos, M., Healey, J. S., Wang, J., Connolly, S. J., Mabo, P., van Erven, L., Kautzner, J., Glikson, M., Neuzner, J., O’Hara, G. E., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.11.020 · Cited by 20
Prevalence of TTR variants detected by whole-exome sequencing in hypertrophic cardiomyopathy
Lopes, L. R., Futema, M., Akhtar, M. M., Lorenzini, M., Pittman, A. M., Syrris, P., & Elliot, P. M. (2019) · Amyloid · doi:10.1080/13506129.2019.1665996 · Cited by 19
Αρσένος, Π., Gatzoulis, K. A., Tsiachris, D., Dilaveris, P., Sideris, S. K., Sotiropoulos, I., Archontakis, S., Antoniou, C. K., Kordalis, A., Skiadas, I., et al. (2022) · World Journal of Cardiology · doi:10.4330/wjc.v14.i3.139 · Cited by 19
Sammani, A., Jansen, M., de Vries, N. M., de Jonge, N., Baas, A. F., Riele, A. S. J. M. T., Asselbergs, F. W., & Oerlemans, M. I. F. J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.768847 · Cited by 19
Prognostic factors in hypertrophic cardiomyopathy in children: An MRI based study
Ait-Alì, L., Marrone, C., Martins, D. S., Khraiche, D., Festa, P., Martini, N., Santoro, G., Todiere, G., Panaioli, E., Bonnet, D., et al. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.06.043 · Cited by 19
O’Hara, R., Prakosa, A., Binka, E., Lacy, A., & Trayanova, N. A. (2022) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2022.09.004 · Cited by 19
Differing strategies for sudden death prevention in hypertrophic cardiomyopathy
Maron, M. S., Rowin, E. J., Spirito, P., & Maron, B. J. (2022) · Heart · doi:10.1136/heartjnl-2020-316693 · Cited by 19
Prediction of worsening heart failure in hypertrophic cardiomyopathy using plasma proteomics
Lumish, H. S., Liang, L. W., Hasegawa, K., Maurer, M. S., Fifer, M. A., Reilly, M. P., & Shimada, Y. J. (2023) · Heart · doi:10.1136/heartjnl-2023-322644 · Cited by 19
Arrhythmogenesis in Fabry Disease
Roy, A., Cumberland, M. J., O’Shea, C., Holmes, A. P., Kalla, M., Gehmlich, K., Geberhiwot, T., & Steeds, R. P. (2024) · Current Cardiology Reports · doi:10.1007/s11886-024-02053-2 · Cited by 19
Management of hypertrophic cardiomyopathy
Zhang, Y., Adamo, M., Zou, C., Porcari, A., Tomasoni, D., Rossi, M., Merlo, M., Liu, H., Wang, J., Zhou, P., et al. (2024) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001616 · Cited by 21
Pöyhönen, P., Lehtonen, J. Y. A., Syväranta, S., Velikanova, D., Mälkönen, H., Simonen, P. P., Nordenswan, H., Uusitalo, V., Vihinen, T., Kaikkonen, K., et al. (2024) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.124.013239 · Cited by 19
The Ups and Downs of Genetic Diagnosis of Hypertrophic Cardiomyopathy
Gómez, J., Reguero, J. R., & Coto, E. (2015) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2015.10.001 · Cited by 19
Role of echocardiography in the diagnosis and management of hypertrophic cardiomyopathy
Domínguez, F., González-López, E., Padrón-Barthe, L., Cavero, M. A., & García‐Pavía, P. (2017) · Heart · doi:10.1136/heartjnl-2016-310559 · Cited by 18
Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Adamczak, D., & Oko‐Sarnowska, Z. (2017) · Cardiology in Review · doi:10.1097/crd.0000000000000184 · Cited by 19
Mills, H., Espersen, K., Jurlander, R. S., Iversen, K. K., Bundgaard, H., & Raja, A. A. (2020) · Clinical Cardiology · doi:10.1002/clc.23351 · Cited by 19
Österberg, A. W., Östman‐Smith, I., Jablonowski, R., Carlsson, M., Gréen, H., Gunnarsson, C., Liuba, P., & Fernlund, E. (2021) · Pediatric Cardiology · doi:10.1007/s00246-020-02506-9 · Cited by 19
Dinshaw, L., Münch, J., Dickow, J., Lezius, S., Willems, S., Hoffmann, B. A., & Patten, M. (2017) · Clinical Research in Cardiology · doi:10.1007/s00392-017-1164-4 · Cited by 19
Keil, L. D., Chevalier, C. M., Kirchhof, P. F., Blankenberg, S., Lund, G., Müllerleile, K., & Magnussen, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137115 · Cited by 18
Prognostic relevance of exercise testing in hypertrophic cardiomyopathy. A systematic review
Rodrigues, T., Raposo, S. C., Brito, D. A., & Lopes, L. R. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.06.051 · Cited by 20
Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy
Liang, L. W., Raita, Y., Hasegawa, K., Fifer, M. A., Maurer, M. S., Reilly, M. P., & Shimada, Y. J. (2022) · Heart · doi:10.1136/heartjnl-2021-320729 · Cited by 18
Aquaro, G. D., Corsi, E., Todiere, G., Grigoratos, C., Barison, A., Barra, V., Bella, G. D., Emdin, M., Ricci, F., & Pingitore, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030651 · Cited by 18
Advanced imaging for risk stratification for ventricular arrhythmias and sudden cardiac death
Xie, E., Sung, E., Saad, E., Trayanova, N. A., Wu, K. C., & Chrispin, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.884767 · Cited by 18
The Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy
Maron, M. S., Rowin, E. J., & Maron, B. J. (2024) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.10.076 · Cited by 18
Hata, Y., Ichimata, S., Yamaguchi, Y., Hirono, K., Oku, Y., Ichida, F., & Nishida, N. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040463 · Cited by 18
Magnusson, P., Nordström, J., Harms, H. J., Lubberink, M., Gadler, F., Sörensen, J., & Mörner, S. (2019) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2019.100452 · Cited by 18
Lipari, M., Wypasek, E., Karpiński, M., Pająk, L. T., Laino, L., Binni, F., Giannarelli, D., Rubiś, P., Dimitrow, P. P., Undas, A., et al. (2020) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.15130 · Cited by 18
Magnusson, P., & Mörner, S. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14792 · Cited by 18
Higuchi, S., Minami, Y., Shoda, M., Shirotani, S., Saito, C., Haruki, S., Gotou, M., Yagishita, D., Ejima, K., & Hagiwara, N. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015064 · Cited by 18
Lu, R., Lumish, H. S., Hasegawa, K., Maurer, M. S., Reilly, M. P., Weiner, S. D., Tower-Rader, A. F., Fifer, M. A., & Shimada, Y. J. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3546 · Cited by 17
Amr, A., Koelemen, J., Reich, C., Sedaghat‐Hamedani, F., Kayvanpour, E., Haas, J., Frese, K., Lehmann, D., Katus, H. A., Frey, N., et al. (2023) · Clinical Research in Cardiology · doi:10.1007/s00392-023-02310-4 · Cited by 18
Noroozi, M., Gholami, M., Sadeghsalehi, H., Behzadi, S., Habibzadeh, A., Erabi, G., Sadatmadani, S.-F., Diyanati, M., Rezaee, A., Dianati, M., et al. (2024) · Applied Neuropsychology Adult · doi:10.1080/23279095.2024.2382823 · Cited by 17
Webb, J., Villa, A. D. M., Bekri, I., Shome, J. S., Teall, T., Claridge, S., Jackson, T., Porter, B., Ismail, T. F., Giovine, G. D., et al. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.01.021 · Cited by 17
Contemporary Septal Reduction Therapy in Drug-Refractory Hypertrophic Obstructive Cardiomyopathy
Maekawa, Y., Akita, K., & Takanashi, S. (2018) · Circulation Journal · doi:10.1253/circj.cj-18-0575 · Cited by 17
Raiker, N. K., Vullaganti, S., Collins, J. D., Allen, B. D., & Choudhury, L. (2020) · International journal of cardiac imaging · doi:10.1007/s10554-020-01808-6 · Cited by 17
Hypertrophic Cardiomyopathy 2020
Kogut, J., & Popjes, E. D. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01381-3 · Cited by 17
Huang, X., Wang, Y.-J., Chen, B.-Y., Huang, Y., Wang, X.-H., Chen, L.-F., Gui, R., & Ma, X.-J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.694733 · Cited by 15
Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction: Expecting the Unexpected
Jain, P., Patel, P. A., & Fabbro, M. (2017) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2017.04.054 · Cited by 17
Sudden cardiac death in hypertrophic cardiomyopathy: time to change the narrative
Elliot, P. M. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab608 · Cited by 17
Helali, J. S., Ramesh, K. K., Brown, J., Preciado-Ruiz, C., Nguyen, T., Silva, L. G. D. C., Ficara, A., Wesbey, G. E., Gonzalez, J. A., Bilchick, K. C., et al. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.132711 · Cited by 16
Gimeno, J. R., Elliot, P. M., Tavazzi, L., Tendera, M., Kaski, J. P., Laroche, C., Villa, R. B., Seferovic, P. M., Biagini, E., Arbustini, E., et al. (2020) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcaa075 · Cited by 16
Self-citationFounder mutation in myosin-binding protein C with an early onset and a high penetrance in males
Méndez, I., Fernández, A. I., Espinosa, M. Á., Cuenca, S., Lorca, R., Rodríguez, J. F., Tamargo, M., Garcia-Montero, M., Gómez, C., Vilches, S., et al. (2021) · Open Heart · doi:10.1136/openhrt-2021-001789 · Cited by 17
Francia, P., Olivotto, I., Lambiase, P. D., & Autore, C. (2021) · EP Europace · doi:10.1093/europace/euab309 · Cited by 16
Memon, A., Larik, M. O., Khan, Z., Urooj, M., Irfan, A., Kumari, B., Faisal, M., Siddiqui, R., Tehrim, M., & Hameed, I. (2023) · Future Science OA · doi:10.2144/fsoa-2023-0059 · Cited by 14
Genetic basis of right and left ventricular heart shape
Burns, R., Young, W. J., Aung, N., Lopes, L. R., Elliot, P. M., Syrris, P., Villa, R. B., Sohrabi, C., Petersen, S. E., Ramírez, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53594-7 · Cited by 18
Hypertrophic cardiomyopathy: A complex disease
Young, L. D., Smedira, N. G., Tower-Rader, A. F., Lever, H. M., & Desai, M. Y. (2018) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.85a.17076 · Cited by 16
From Hypertrophy to Heart Failure: What Is New in Genetic Cardiomyopathies
Reza, N., Musunuru, K., & OWENS, A. T. (2019) · Current Heart Failure Reports · doi:10.1007/s11897-019-00435-0 · Cited by 17
Figuero, S. B., Garcı́a-Alberola, A., Rubio, J., Segura, J. M., Rodríguez, A., Peinado, R., Alzueta, J., Martínez-Ferrer, J., Viñolas, X., de la Concha, J. F., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.018108 · Cited by 16
Bosman, L. P., Gerlach, C. L. N., Cadrin‐Tourigny, J., Orgeron, G. M., Tichnell, C., Murray, B. A., Bourfiss, M., van der Heijden, J. F., Yap, S., Zeppenfeld, K., et al. (2021) · EP Europace · doi:10.1093/europace/euab162 · Cited by 16
Castelletti, S., Zorzi, A., Ballardini, E., Basso, C., Biffi, A., Brancati, F., Cavarretta, E., Crotti, L., Contursi, M., D'Aleo, A., et al. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.05.071 · Cited by 16
Roldan, P. C., Ravi, S., Hodovan, J., Belcik, J. T., Heitner, S. B., Masri, A., & Lindner, J. R. (2022) · Cardiovascular Ultrasound · doi:10.1186/s12947-022-00293-2 · Cited by 16
Ma, X., Tang, Y., Chen, X., Yang, S., Wang, J., Yang, K., Dong, Z., Wei, Z., Jia, X., Liu, Y., et al. (2025) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2025.08.019 · Cited by 15
Huang, F., Shah, J. P., Pu, X., Hagar, A., & Chen, S.-J. (2020) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2020.05.017 · Cited by 15
Jansen, M., Schuldt, M., van Driel, B., Schmidt, A. F., Christiaans, I., van der Crabben, S. N., Hoedemaekers, Y. M., Dooijes, D., Jongbloed, J. D. H., Boven, L. G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044031 · Cited by 15
Gendiagnostik bei kardiovaskulären Erkrankungen
Schulze‐Bahr, E., Klaassen, S., Gerull, B., Kodolitsch, Y. V., Landmesser, U., Rieß, O., Meder, B., & Schunkert, H. (2023) · Die Kardiologie · doi:10.1007/s12181-023-00622-3 · Cited by 15
Metadata
- Authors
- O'Mahony, C., Jichi, F., Pavlou, M., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., McKenna, W. J., Omar, R. Z., Elliott, P. M., & for the Hypertrophic Cardiomyopathy Outcomes Investigators
- Affiliations
- University College London (GB)
- National and Kapodistrian University of Athens (GR)
- University of Bologna (IT)
- Hospital Universitario Virgen de la Arrixaca (ES)
- University of Campania "Luigi Vanvitelli" (IT)
- University College Hospital at Westmoreland Street (GB)
- ORCID
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-10-14
- Volume
- 35
- Issue
- 30
- Pages
- 2010-2020
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2119361626
- Cited by
- 1,251
- References
- 50
- Citations by year
- 2026: 107 · 2025: 124 · 2024: 115 · 2023: 120 · 2022: 99 · 2021: 125 · 2020: 116 · 2019: 87 · 2018: 81 · 2017: 100 · 2016: 67 · 2015: 76 · 2014: 31 · 2013: 2
- FWCI
- 39.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Hispana (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- RUNA. Repositorio Institucional del Sergas (Servicio Gallego de Salud (SERGAS)) (submittedVersion, other-oa)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Funders
- National Institute for Health and Care Research (NF-SI-0509-10230)
- Università di Bologna
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- hypertrophic cardiomyopathy, sudden cardiac death, risk prediction model, individualized risk estimation, implantable cardioverter-defibrillator, left ventricular wall thickness, left ventricular outflow tract gradient, family history of sudden cardiac death, non-sustained ventricular tachycardia, unexplained syncope, left atrial diameter, model validation
- MeSH terms
- Adult, Cardiomyopathy, Hypertrophic, Female, Humans, Male, Middle Aged, Prognosis, Retrospective Studies, Reproducibility of Results, Proportional Hazards Models, Death, Sudden, Cardiac, Sample Size, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
